The data also suggests that the mismatch between CEST maps obtained with different models (asymmetry-based (AB) and fluid-suppressed (FS)) can be used to identify subgroups in IDH-mutant_1p/19qret gliomas that could potentially have prognostic and clinical relevance. The gene discussed is IDH1; the disease is central nervous system cancer.